Generics Bulletin Explains: The Next Wave Of US Humira Biosimilars

Start Of July Will See An Explosion Of Competition On Adalimumab In US From Eight Rivals

 
• By David Wallace
  
Black running track with white markings for positions 1 to 8
Eight further FDA-approved Humira biosimilars are set to launch • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products